UA75101U - method for elimination of metabolic disorders in animals using anthelmintics Klozaverm-A - Google Patents

method for elimination of metabolic disorders in animals using anthelmintics Klozaverm-A

Info

Publication number
UA75101U
UA75101U UAU201204137U UAU201204137U UA75101U UA 75101 U UA75101 U UA 75101U UA U201204137 U UAU201204137 U UA U201204137U UA U201204137 U UAU201204137 U UA U201204137U UA 75101 U UA75101 U UA 75101U
Authority
UA
Ukraine
Prior art keywords
klozaverm
anthelmintics
animals
elimination
metabolic disorders
Prior art date
Application number
UAU201204137U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Александр Леонидович Тишин
Игорь Ярославович Коцюмбас
Ксения Алексеевна Высоцкая
Марьяна Игоревна Пелешак
Андрей Алексеевич Высокций
Original Assignee
Львовский Национальный Университет Ветеринарной Медицины И Биотехнологий Имени С.З. Гжицкого
Государственный Научно-Исследовательский Контрольный Институт Ветеринарных Препаратов И Кормовых Добавок
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Львовский Национальный Университет Ветеринарной Медицины И Биотехнологий Имени С.З. Гжицкого, Государственный Научно-Исследовательский Контрольный Институт Ветеринарных Препаратов И Кормовых Добавок filed Critical Львовский Национальный Университет Ветеринарной Медицины И Биотехнологий Имени С.З. Гжицкого
Priority to UAU201204137U priority Critical patent/UA75101U/en
Publication of UA75101U publication Critical patent/UA75101U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for elimination of metabolic disorders in animals using anthelmintics Klozaverm-A comprises the use of anthelmintic drug in combination with immunomodulators. As immunomodulator drug E-selenium is used, which is administered to animals parenterally at a dose of 0.02 ml/kg of body weight once simultaneously with the therapeutic dose of anthelmintics Klozaverm-A.
UAU201204137U 2012-04-03 2012-04-03 method for elimination of metabolic disorders in animals using anthelmintics Klozaverm-A UA75101U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201204137U UA75101U (en) 2012-04-03 2012-04-03 method for elimination of metabolic disorders in animals using anthelmintics Klozaverm-A

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201204137U UA75101U (en) 2012-04-03 2012-04-03 method for elimination of metabolic disorders in animals using anthelmintics Klozaverm-A

Publications (1)

Publication Number Publication Date
UA75101U true UA75101U (en) 2012-11-26

Family

ID=50843854

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201204137U UA75101U (en) 2012-04-03 2012-04-03 method for elimination of metabolic disorders in animals using anthelmintics Klozaverm-A

Country Status (1)

Country Link
UA (1) UA75101U (en)

Similar Documents

Publication Publication Date Title
IL239488A0 (en) Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective
IN2014DN09434A (en)
MX2015002669A (en) Methods of administering pirfenidone therapy.
MY184292A (en) Substituted aminopyrimidine compounds and methods of use
NZ732507A (en) Improved compositions for treating muscular dystrophy
MX2019006739A (en) Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same.
MY174188A (en) Heterocyclyl compounds
IN2012DN06720A (en)
EP4360621A3 (en) Formulations of bendamustine
MX2017003780A (en) Pharmaceutical composition for treating ulcerative colitis.
MX360409B (en) Fixed dose combination therapy of parkinson's disease.
MX356317B (en) Treatment of symptoms associated with female gastroparesis.
MX2019006942A (en) Non-peptide oxytocin receptor agonists.
MX368640B (en) PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION and PAIN.
TW201613606A (en) Therapeutic drug for chronic renal failure
UA75101U (en) method for elimination of metabolic disorders in animals using anthelmintics Klozaverm-A
MY169733A (en) Crustacean feed
MX2015016678A (en) Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid.
GEP20196947B (en) Bremelanotide therapy for female sexual dysfunction
RU2012149676A (en) METHOD FOR TREATING CALVES WITH PATIENTS WITH SIMULIIDOTOXICOSIS
UA91081U (en) Method for simulation of cataract
UA74882U (en) Pharmaceutical composition for treatment of sexual dysfunction
UA69941U (en) Method for modeling porphyrin metabolism disorder in the brain
UA92302C2 (en) Drug for therapy of malignant tumors and method for treatment of malignant tumors using said drug
UA78292U (en) Method for preventing acute conditions of chronic bronchitis in insulin-resistant patients